Alantos Pharmaceuticals (acquired by Amgen) Company
.png)
Alantos Pharmaceuticals is a chemistry-driven biopharmaceutical company. It engages in the discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes. Their products include Dipeptidyl and Peptidase IV inhibitor. The company offers various tissue remodeling pathways for rheumatoid arthritis, liver fibrosis, cardiovascular, chronic wound healing, and cancer. Alantos Pharmaceuticals was founded in 2002 and is based in Cambridge, Massachusetts.
Industry:
Geroscience
Headquarters:
Cambridge, Massachusetts, United States
Zip:
10001+
Founded Date:
2002-01-01
Employees Number:
10001+
Acquisitions Number:
6
Investors Number:
47700000
Total Funding:
47700000
Estimated Revenue:
2007-06-06
Last Funding Date:
Series B
Last Funding Type:
investor.relations@amgen.com
Register and Claim Ownership